Haemophilia trials in Czechia

5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

  Where

  Brno

  Age

  1 year to 74 years

  People

  245 worldwide

  Run by

  Pfizer

  See details and how to joinNCT05145127 · EU 2022-500470-33-00
• Phase 3Taking people
  A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

  Where

  Brno, Prague

  Age

  1 year to 17 years

  People

  100 worldwide

  Run by

  Pfizer

  See details and how to joinNCT05611801 · EU 2022-500495-65-00
• No phaseEnrolling by invitation
  A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN

  Where

  Brno, Pilsen

  People

  60 worldwide

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT03745924
• No phaseEnrolling by invitation
  A Study Following Males With Haemophilia A on Prophylaxis With Esperoct®

  Where

  Brno, Hradec Králové

  People

  60 worldwide

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT04574076
• No phaseTaking people
  The European Paediatric Network for Haemophilia Management ( PedNet Registry)

  Where

  Brno, Prague

  People

  4,000 worldwide

  Run by

  PedNet Haemophilia Research Foundation

  See details and how to joinNCT02979119